Emerging Business Models in the Pharmaceutical Industries ...

Market Segmentation Getting Blurred
The pharma industry spans pharma, medical equipment,
and health care services. Pharma is no longer restricted
to white powder drugs, and includes therapeutic health
care packages covering diagnostic tests, drugs,
monitoring devices and other support services for
patients. The market size of the industry is increasing as
a result of personalised biotech drugs blurring the
distances between the vertical segments of drugs,
medical equipment and health care.
Winning Strategies
The Big Pharma companies are facing the pressure of
trying to stay stable even while being innovative in their
products and approach.
The companies are formulating winning strategies on
the basis of new emerging models such as the Kiosk
Based Health Care Model, Integrated Network Model,
and Semi Block Buster Model.
The primary business and operational goals of pharma
companies are to increase market capitalisation to gain
institutional support, raise additional funding, optimise
R&D process and reduce cost, acquire later stage
programmes and pipelines, and bank on competitive
advantages.
Strategic Analysis of the Pharma Market, Future Revenue Models and Key Players 9